암조직 선택성과 생분해성을 갖는 고리형 삼합체포스파젠-백금(II) 착물 컨쥬게이트 항암제 및 그 제조방법
    1.
    发明授权
    암조직 선택성과 생분해성을 갖는 고리형 삼합체포스파젠-백금(II) 착물 컨쥬게이트 항암제 및 그 제조방법 失效
    肿瘤选择性和生物可降解的环磷酰胺铂(II)偶联抗原剂及其制备方法

    公开(公告)号:KR100807358B1

    公开(公告)日:2008-02-28

    申请号:KR1020070038055

    申请日:2007-04-18

    Applicant: (주)씨앤팜

    CPC classification number: C07F15/0093

    Abstract: A cyclotriphosphazene-platinum(II) conjugate is provided to show high selectivity on a cancer tissue and excellent anticancer effect due to excellent permeation-retention property effect on the cancer tissue. A cyclotriphosphazene-platinum(II) conjugate is represented by the formula(1), where n is 7, 12 or 16; m is 0, 1 or 2; x is 1; each y and z is respectively 0 or 1; and each R, R' and R' is respectively selected from the group consisting of (CH3)2CH-, (CH3)2CHCH2-, (C2H5)(CH3)CH- and (C6H5)CH2-; and A and A' are independently an amine monodendate or A and A' may bound to each other to form a chelate type diamine didendate. An anticancer composition comprises the cyclotriphosphazene-platinum(II) conjugate as an effective ingredient. A method for preparing the conjugate comprises the steps of: (a) hydrolyzing a cyclotriphosphazene represented by the formula(3) to prepare an alkali metal salt or an alkali earth metal salt thereof represented by the formula(4); and (b) coupling the compound of the formula(4) to a (diamine) platinum(II) complex represented by the formula(5), where the n, m, x, y, z, R, R', R", A and A' are same as defined above; M is two alkali metal ions selected from the group consisting of potassium ion and sodium ion or Ba^2+; and L is one or two anion ligand(s) selected from the group consisting of sulfuric acid ion and nitric acid ion.

    Abstract translation: 提供了一种环三磷腈 - 铂(II)缀合物,以显示对癌组织的高选择性,并且由于对癌组织的优异的渗透保留性效应而具有优异的抗癌作用。 环三磷腈 - 铂(II)缀合物由式(1)表示,其中n为7,12或16; m为0,1或2; x为1; 每个y和z分别为0或1; 并且每个R,R'和R'分别选自(CH 3)2 CH-,(CH 3)2 CHCH 2 - ,(C 2 H 5)(CH 3)CH-和(C 6 H 5)CH 2 - ; 并且A和A'独立地是单一单胺或A和A'可以彼此结合以形成螯合型二胺胺二酸酯。 抗癌组合物包含环三磷腈 - 铂(II)缀合物作为有效成分。 制备共轭物的方法包括以下步骤:(a)水解由式(3)表示的环三磷腈以制备由式(4)表示的碱金属盐或碱土金属盐; 和(b)将式(4)的化合物与由式(5)表示的(二胺)铂(II)络合物偶合,其中n,m,x,y,z,R,R',R“ ,A和A'与上述相同; M是选自钾离子和钠离子或Ba 2+的两种碱金属离子; L是选自以下的一种或两种阴离子配体: 的硫酸离子和硝酸离子。

Patent Agency Ranking